The incidence of cheilitis during cycles of chemotherapy in breast cancer patients

Abstract

According to various authors, the development of the side effects of cytostatic therapy in the oral cavity occurs in 10–40 % of cases. The conduction of the I cycle of chemotherapy in breast cancer patients was accompanied in 65.4 ± 9.5 % (in 17 of 26 patients) by the development of cheilitis. Marked a further decline in the manifestations of cheilitis in the V and VI CTx cycles – 50.0 ± 10.0 and 34.6 ± 9.5 % respectively. The foregoing dictates the need for monitoring the state of the organs of oral cavity during chemotherapy in breast cancer patients.